Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nephrol Dial Transplant ; 19(2): 337-41, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14736956

ABSTRACT

BACKGROUND: To test the hypothesis that nephron mass is an independent determinant of arterial pressure, the effects of augmenting renal mass by isograft transplantation were studied in the model of secondary hypertension. METHODS: The effects of isograft transplantation or sham operation on blood pressure, proteinuria, remnant kidney mass, glomerular filtration rate and glomerulosclerosis were assessed in 5/6 nephrectomized (5/6 NPX) rats. RESULTS: Systolic blood pressure was lowered on average by approximately 35 mmHg and glomerular hyperfiltration was attenuated in the remnant kidneys of transplant recipients. Markedly lower urinary protein excretion rates and glomerulosclerosis scores in the remnant kidney accompanied these supplemental transplants to values roughly one-third of those from sham-operated rats. CONCLUSIONS: The data show that reduced renal mass per se is the major factor in the development and maintenance of arterial hypertension and glomerular injury in 5/6 NPX rats and these changes can be reversed by supplementing renal mass. The data provide strong support for the notion that renal mass is a significant, independent determinant of arterial pressure.


Subject(s)
Hypertension, Renal/physiopathology , Kidney Transplantation , Proteinuria/physiopathology , Animals , Blood Pressure Determination , Disease Models, Animal , Disease Progression , Female , Glomerular Filtration Rate , Male , Nephrectomy , Organ Size , Rats , Rats, Wistar , Reference Values , Renal Circulation/physiology , Risk Assessment , Sensitivity and Specificity , Transplantation, Isogeneic
2.
Transplantation ; 74(3): 307-14, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12177607

ABSTRACT

BACKGROUND: Systemic hypertension affects many allograft recipients, is an important risk factor for chronic graft dysfunction, and is linked to reduced graft survival. The condition may up-regulate the expression of inflammatory host cells and their products. These, in turn, may significantly injure vascular endothelium and other components of allografted kidneys. METHODS: Lewis rats received orthotopic F344 renal allografts, a standard model of chronic rejection. Renovascular hypertension was produced by placing a silver clip (0.25 mm) on the renal artery of the retained contralateral native kidney 4 weeks after transplantation. Sham-clipped rats served as normotensive controls. Four recipient groups (Gp) were studied: Gp 1, rats with an allograft plus a clipped native kidney; Gp 2, those with an allograft and a sham-clipped native kidney; Gp 3, isografted animals with a clipped native kidney; and Gp 4, those bearing an isograft and a sham-clipped native kidney. Systolic blood pressure and proteinuria were measured every 2 weeks for 24 weeks. Grafts were assessed serially for morphologic and immunohistologic changes. RESULTS: Systemic blood pressure rose to hypertensive levels in Gps 1 and 3 within a week of clipping but never increased in Gps 2 and 4. Proteinuria developed in hypertensive animals but remained at baseline in normotensive controls. Intimal thickening of allograft arteries progressed to luminal obliteration with extensive perivascular and interstitial fibrosis by 24 weeks. In contrast, vascular changes in isografts of hypertensive hosts were restricted to medial hypertrophy. Tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta, platelet derived growth factor (PDGF), endothelin, Il-6, major histocompatibility complex (MHC) class II, and B7 were up-regulated in allografts in hypertensive hosts. Vascular deposition of immunoglobulin (IgG) was increased. These changes were markedly less pronounced in Gp 3 isografts and minimal in the kidneys of the normotensive animals of Gps 2 and 4. CONCLUSIONS: An experimental model is presented that examines the influence of recipient hypertension in the pathogenesis of chronic dysfunction and injury developing in rat renal allografts over time.


Subject(s)
Blood Pressure/physiology , Graft Survival/physiology , Hypertension, Renal/complications , Kidney Transplantation/pathology , Kidney Transplantation/physiology , Animals , Biomarkers/analysis , Elastin/analysis , Graft Survival/immunology , Hypertrophy , Male , Rats , Rats, Inbred F344 , Rats, Inbred Lew , Rats, Sprague-Dawley , Transplantation, Homologous , Transplantation, Isogeneic/physiology
3.
J Biol Chem ; 277(12): 9707-12, 2002 Mar 22.
Article in English | MEDLINE | ID: mdl-11784718

ABSTRACT

High extracellular glucose plays a pivotal role in the pathophysiology of diabetic nephropathy. Here we report 200 genes, identified using suppression-subtractive hybridization, that are differentially expressed when human mesangial cells are propagated in high ambient glucose in vitro. The major functional classes of genes identified included modulators and products of extracellular matrix protein metabolism, regulators of cell growth and turnover, and a cohort of actin cytoskeleton regulatory proteins. Actin cytoskeletal disassembly is a prominent feature of diabetic nephropathy. The induction of actin cytoskeleton regulatory gene expression by high glucose was attenuated by the inhibitor of reactive oxygen species generation, carbonyl cyanide m-chlorophenylhydrazone but not by the protein kinase C inhibitor GF 109203X and was not mimicked by the addition of transforming growth factor beta. Enhanced expression of actin cytoskeleton regulatory genes was also observed following disruption of the mesangial cell actin cytoskeleton by cytochalasin D. In aggregate, these results suggest that the induction of genes encoding actin cytoskeleton regulatory proteins (a) is a prominent component of the mesangial cell transcriptomic response in diabetic nephropathy and (b) is dependent on oxidative stress, is independent of protein kinase C and transforming growth factor-beta, and represents an adaptive response to actin cytoskeleton disassembly.


Subject(s)
Contractile Proteins , Cytoskeleton/metabolism , Gene Expression Regulation , Glomerular Mesangium/cytology , Glucose/metabolism , Oxidative Stress , Actins/metabolism , Animals , Blotting, Northern , Cell Line , Cells, Cultured , Cytochalasin D/pharmacology , DNA, Complementary/metabolism , Diabetes Mellitus, Experimental/metabolism , Enzyme Inhibitors/pharmacology , Glomerular Mesangium/metabolism , Humans , Indoles/pharmacology , Kidney/metabolism , Maleimides/pharmacology , Microfilament Proteins/biosynthesis , Molecular Sequence Data , Nucleic Acid Hybridization , Oxygen/metabolism , Profilins , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/physiology , Rats , Rats, Wistar , Reactive Oxygen Species , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta1 , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL